Soluble fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis

Arthritis and Rheumatism

Volumn 41, Issue 4, 1998, Pages 657-662

  Hashimoto, Hideo ^a   Tanaka, Masato ^a   Suda, Takashi ^b   Tomita, Tetsuya ^a   Hayashida, Kenji ^a   Takeuchi, Eiji ^a   Kaneko, Motoharu ^a   Takano, Hiroshi ^a   Nagata, Shigekazu ^a   Ochi, Takahiro ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

AGED; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION; HUMANS; KNEE JOINT; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS; RNA, MESSENGER; SOLUBILITY; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0031900570     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199804)41:4<657::AID-ART12>3.0.CO;2-N     Document Type: Article

References (27)

1. Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanism of joint destruction in rheumatoid arthritis: two cellar mechanisms explain joint destruction? Ann Rheum Dis 1993;52:39-47.
2. Gay S, Gay RE. Cellular basis and oncogene expression of rheumatoid joint destruction. Rheumatol Int 1989;9:105-13.
3. Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Fassbender HE, Gay S. Spontaneous expression of immediately early response genes c-fos and erg-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheumatol Int 1992;12:53-9.
4. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5.
5. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485-91.
6. Firestein G, Yeo M, Zvaifler N. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
7. Fujisawa K, Asahara H, Okamoto K, Aono H, Hasunuma T, Kobata T. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J Clin Invest 1996;98:271-8.
8. Ito MR, Terasaki S, Itoh J, Katoh H, Yonehara S, Nose M. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand. Arthritis Rheum 1997;40:1054-63.
9. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
10. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995;14:1129-35.
11. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF. A metalloproteinase disintegrin that releases tumor-necrosis factor-alpha from cells. Nature 1997;385:729-33.
12. Moss ML, Jin SL, Milla ME, Burkhart W, Carter HL, Chen WJ. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-alpha. Nature 1997;385:733-6.
13. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F. Fas ligand in human serum. Nat Med 1996;2:317-22.
14. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocyte and soluble Fas ligand blocks the killing. J Exp Med 1997;186:2045-50.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Ochi T, Iwase R, Yonemasu K, Matsukawa M, Yoneda M, Yukioka M, et al. Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:37-43.
17. Tanaka M, Suda T, Yatomi T, Nakamura N, Nagata S. Lethal effect of recombinant human Fas ligand in mice pretreated with propionibacterium acnes. J Immunol 1996;158:2303-9.
18. Suda T, Tanaka M, Miwa K, Nagata S. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J Immunol 1996;157:3918-24.
19. MÜller-Lander U, Kriegsmann J, Tschopp J, Gay RE, Gay S. Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:477-84.
20. Kummer JA, Tak PP, Brinkman B, van Tilborg AAG, Kamp AM, Daha MR. Expression of granzyme A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol 1994;73:88-95.
21. Tak PP, Kummer JA, Hack CE, Daha MR, Smeets TJM, Erkelens GW, et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 1994;37:1735-43.
22. Nagata S, Golstein P. The Fas death factor. Science 1995;267: 1449-56.
23. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
24. Okamoto K, Fujisawa K, Hasunuma T, Kobata T, Sumida T, Nishioka K. Selective activation of the JNK/AP-1 pathway in Fas-mediated apoptosis of rheumatoid arthritis synoviocytes. Arthritis Rheum 1997;40:919-26.
25. Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 1995;182:449-57.
26. Lee BO, Ishihara K, Denno K, Kobune Y, Itoh M, Muraoka O, et al. Elevated levels of the soluble form of bone marrow stromal cell antigen 1 in the sera of patients with severe rheumatoid arthritis. Arthritis Rheum 1996;39:629-37.
27. Tomita T, Kashiwagi N, Shimaoka Y, Ikawa T, Tanabe M, Nakagawa S, et al. Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis. J Rheumatol 1994;21:1608-14.